...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: you won’t see anyone buying this

fuzzy, would you be concerned about a stock dilution if you're offered $5 for your "ZHCLF" shares?

 

Koo

Share
New Message
Please login to post a reply